Author | Scott S. Tykodi, MD, PhD

Articles

Scott Tykodi, MD, PhD, on Takeaways from KEYNOTE-427 in Renal Cell Carcinoma

July 24, 2020

The Seattle Cancer Care Alliance expert discusses key takeaways from cohort a of the KEYTRUDA-427 study, evaluating pembrolizumab monotherapy in patients with clear cell renal cell carcinoma.

Scott Tykodi, MD, PhD, Discusses Biomarker Detection, Analysis in RCC

July 13, 2020

The Seattle Cancer Care Alliance Expert offered background on cohort A of the KEYNOTE-427 trial.

Scott Tykodi, MD, PhD, on Results from the KEYNOTE-427 Trial

June 21, 2020

The Seattle Cancer Care Alliance Expert offered background on the first-line use of pembrolizumab monotherapy in advanced clear cell renal cell carcinoma.

Systemic Therapy of Metastatic Melanoma: On the Road to Cure

February 15, 2015

In this article, we summarize the systemic therapies now available for melanoma, with a focus on the recently approved agents for cutaneous melanoma; discuss important considerations in selecting a treatment from the available options; and highlight some of the promising investigational approaches for this disease.